Robeauté raises $28 million for neurosurgical microrobotics
Robeauté raised $28 million to advance its microrobotic platform for navigating brain tissue and prepare the technology for clinical development.
Evidence notes
- Plural, Cherry Ventures and Brainlab participated in the financing.
- The platform is designed for diagnosis, monitoring and local treatment through a minimally invasive entry point.
- The round supports development and clinical translation of the company’s neurosurgical system.